S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
NKTX · Nkarta, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$1.75
+0.01
(+0.57%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$1.75
$1.74
$1.81
52-WEEK RANGE
$1.75
$1.70
$3.72
What's happening
- NKTX is up 0.57% today, trading at $1.75. — Live quote
- It's trading within 3% of its 52-week low ($1.70). (Finnhub fundamentals)
- Volume today (117,957) is well below its 3-month average of 692,870. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.54 actual vs. $-0.38 estimated (-40.8%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 8
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (13 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
NKTX
-5.95%
vs S&P 500
-18.72%
1-YEAR RETURN
NKTX
-28.69%
vs S&P 500
-43.25%
6-MONTH RETURN
NKTX
-37.86%
3-MONTH RETURN
NKTX
-32.56%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.54
Est. $-0.38
MISS -40.8%
2026-04-26 (Q1 2026)
$-0.37
Est. $-0.38
BEAT +2.6%
2026-01-26 (Q4 2025)
$-0.37
Est. $-0.32
MISS -14.1%
2025-10-26 (Q3 2025)
$-0.29
Est. $-0.32
BEAT +9.3%
Valuation Measures & Ratios
Enterprise Value4$102.2M
Forward P/E5—
PEG Ratio6-0.17
Price / Sales (TTM1)1060.05
Price / Book70.82
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin—
Operating Margin—
Return on Equity (ROE8)-39.64%
Return on Assets (ROA9)-30.45%
Avg Volume (3M)692,870
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $211.2M | $158.7M | $155.7M | $122.3M | $137.2M |
| P/E | -1.87 | -1.52 | -1.48 | -1.13 | -1.19 |
| Price/Book | 0.85 | 0.56 | 0.46 | 0.34 | 0.36 |
| EV/EBITDA | -1.57 | -1.17 | -0.83 | — | — |
| ROE | -45.57% | -36.56% | -31.08% | -30.28% | -30.32% |
| ROA | -33.44% | -28.09% | -24.58% | -24.16% | -24.40% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short3,661,385
Change from Prior Settlement+4.42%
% of Float—
Days to Cover (Short Ratio)5.89
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 10-Q, filed 2026-08-10; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Trailing 52-week price return is -28.7%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on NKTX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Operating income | -$43.1M | -$30.9M | -$27.3M | -$27.2M | -$36.6M | -$33.8M | -$30.7M | -$32.8M |
| Net income | -$40.4M | -$27.8M | -$21.7M | -$23.0M | -$32.0M | -$28.3M | -$25.0M | -$29.5M |
| EPS (diluted) | $-0.54 | $-0.37 | $-0.29 | $-0.31 | $-0.43 | $-0.39 | $-0.34 | $-0.58 |
| EPS (basic) | $-0.54 | $-0.37 | $-0.29 | $-0.31 | $-0.43 | $-0.39 | $-0.34 | $-0.58 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $337.6M | $372.1M | $404.2M | $427.2M | $448.3M | $470.6M | $501.2M | $532.0M |
| Total liabilities | $89.9M | $86.2M | $91.9M | $89.3M | $90.6M | $91.8M | $93.2M | $101.2M |
| Stockholders' equity | $247.7M | $285.9M | $312.3M | $337.9M | $357.7M | $378.8M | $408.0M | $430.9M |
| Total current assets | $188.0M | $235.9M | $282.5M | $289.3M | $296.6M | $271.6M | $273.3M | $290.1M |
| Total current liabilities | $23.6M | $18.2M | $22.3M | $19.0M | $18.9M | $18.8M | $18.9M | $22.5M |
| Cash & equivalents | $25.0M | $27.4M | $39.6M | $60.1M | $53.4M | $52.6M | $27.9M | $57.0M |
| Marketable securities (current) | $157.8M | $203.1M | $236.6M | $222.2M | $236.3M | $212.9M | $239.5M | $226.1M |
| Other current assets | — | — | $2.4M | — | — | — | $2.7M | — |
| Marketable securities (non-current) | $57.7M | $33.6M | $16.1M | $31.4M | $41.6M | $83.7M | $110.4M | $119.5M |
| Property, plant & equipment | $56.8M | $64.4M | $66.7M | $64.4M | $70.3M | $72.6M | $74.7M | $76.2M |
| Other non-current assets | $1.5M | $1.6M | $1.7M | $1.8M | $2.0M | $4.5M | $4.1M | $4.6M |
| Accounts payable | $3.8M | $1.6M | $2.1M | $1.4M | $1.5M | $1.5M | $638.0K | $1.9M |
| Accrued liabilities | $12.5M | $9.5M | $13.3M | $11.2M | $10.5M | $11.3M | $12.2M | $13.8M |
| Other non-current liabilities | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | — |
| Common stock & paid-in capital | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained earnings | -$716.5M | -$676.1M | -$648.3M | -$620.9M | -$599.2M | -$576.2M | -$544.2M | -$518.3M |
| Accumulated other comprehensive income (loss) | -$425.0K | -$130.0K | $407.0K | $536.0K | $362.0K | $652.0K | $674.0K | $1.7M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$24.2M | -$28.2M | -$21.6M | -$18.7M | -$18.8M | -$29.6M | -$24.8M | -$24.5M |
| Investing cash flow | $21.1M | $15.9M | $1.1M | $25.4M | $19.5M | $54.3M | -$4.5M | -$38.9M |
| Financing cash flow | $676.0K | $6.0K | $64.0K | $0 | $77.0K | $0 | $184.0K | $2.0K |
| Free cash flow | -$24.4M | -$28.6M | -$22.2M | -$18.7M | -$18.9M | -$30.1M | -$25.9M | -$25.3M |
| Capital expenditures | $183.0K | $413.0K | $560.0K | -$8.0K | $138.0K | $518.0K | $1.1M | $777.0K |
| Depreciation & amortization | $2.7M | $2.3M | $6.9M | $2.3M | $2.3M | $2.3M | $6.9M | $2.4M |
| Share-based compensation | $1.9M | $1.9M | $5.7M | $1.8M | $2.1M | $2.8M | $12.4M | $4.1M |
| Purchases of investments | $42.4M | $54.3M | $91.4M | $57.8M | $68.8M | $20.6M | $85.7M | $106.3M |
| Sales/maturities of investments | $0 | $4.0M | $14.0M | $13.0M | $10.0M | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — |
| Operating income | -$122.0M | -$128.2M | -$131.7M | -$119.0M | -$86.4M |
| Net income | -$104.1M | -$108.8M | -$117.5M | -$113.8M | -$86.1M |
| EPS (diluted) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 |
| EPS (basic) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $404.2M | $501.2M | $378.9M | $472.9M | $273.9M |
| Total liabilities | $91.9M | $93.2M | $105.6M | $100.7M | $22.9M |
| Stockholders' equity | $312.3M | $408.0M | $273.3M | $372.2M | $251.0M |
| Total current assets | $282.5M | $273.3M | $253.1M | $360.7M | $245.8M |
| Total current liabilities | $22.3M | $18.9M | $23.3M | $22.0M | $12.9M |
| Cash & equivalents | $39.6M | $27.9M | $31.0M | $37.5M | $60.8M |
| Marketable securities (current) | $236.6M | $239.5M | $217.1M | $314.6M | $177.3M |
| Other current assets | $2.4M | $2.7M | $1.6M | $2.9M | $3.2M |
| Marketable securities (non-current) | $16.1M | $110.4M | — | — | — |
| Property, plant & equipment | $66.7M | $74.7M | $79.3M | $61.9M | $12.9M |
| Other non-current assets | $1.7M | $4.1M | $3.8M | $1.9M | $1.5M |
| Accounts payable | $2.1M | $638.0K | $3.7M | $1.8M | $1.1M |
| Accrued liabilities | $13.3M | $12.2M | $13.6M | $16.0M | $9.3M |
| Other non-current liabilities | $87.0K | $87.0K | — | — | $18.0K |
| Common stock & paid-in capital | $7.0K | $7.0K | $5.0K | $5.0K | $3.0K |
| Retained earnings | -$648.3M | -$544.2M | -$435.4M | -$317.9M | -$204.1M |
| Accumulated other comprehensive income (loss) | $407.0K | $674.0K | $8.0K | -$679.0K | -$150.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$88.7M | -$99.7M | -$86.2M | -$57.0M | -$67.9M |
| Investing cash flow | $100.3M | -$129.6M | $79.0M | -$184.7M | $32.5M |
| Financing cash flow | $141.0K | $226.1M | $691.0K | $219.0M | $1.2M |
| Free cash flow | -$89.9M | -$104.1M | -$114.3M | -$104.1M | -$73.0M |
| Capital expenditures | $1.2M | $4.4M | $28.1M | $47.1M | $5.0M |
| Depreciation & amortization | $9.2M | $9.2M | $5.9M | $2.6M | $1.8M |
| Share-based compensation | $8.6M | $16.7M | $17.2M | $16.9M | $14.5M |
| Purchases of investments | $238.6M | $406.4M | $260.2M | $385.9M | — |
| Sales/maturities of investments | $37.0M | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding NKTX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-06-18 to 2026-06-18
Recent transactions
- Insiders have net sold 1,776 shares over the last 182 days, across 0 purchases and 1 sale.
- Most recent: HASTINGS PAUL J (Chief Executive Officer) — Open market sale of 1,776 shares on 2026-06-18.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)1,776 sh(1 txns)
Net Shares-1,776
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| HASTINGS PAUL J | Chief Executive Officer | Open market sale | 2026-06-18 | 1,776 |
| Mahmood Nadir | President | Open market sale | 2026-01-15 | 5,649 |
| Rose Shawn Marshall | See Remarks | Grant / award | 2026-01-06 | 70,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-18 | HASTINGS PAUL J | Chief Executive Officer | Open market sale | 1,776 | $2.71 |
| 2026-01-15 | HASTINGS PAUL J | Chief Executive Officer | Open market sale | 26,046 | $2.07 |
| 2026-01-15 | Mahmood Nadir | President | Open market sale | 5,649 | $2.07 |
| 2026-01-06 | Rose Shawn Marshall | See Remarks | Grant / award | 70,000 | $0.00 |
| 2026-01-06 | Mahmood Nadir | President | Grant / award | 80,000 | $0.00 |
| 2026-01-06 | HASTINGS PAUL J | Chief Executive Officer | Grant / award | 94,000 | $0.00 |
| 2025-06-18 | HASTINGS PAUL J | Chief Executive Officer | Open market sale | 1,790 | $1.79 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:34 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-10 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-11 | 8-K | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
Recent news
Headlines about NKTX (Nkarta, Inc.). Links open the publisher — we don’t host full articles.
-
Nkarta Targets ACR 2026 Data Reveal as Outpatient CAR NK Trials Advance
Yahoo Finance · 2026-09-27 -
Nkarta to Participate in September Investor Conferences
Yahoo Finance · 2026-09-10 -
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Yahoo Finance · 2026-09-08 -
Nkarta: 'Hold' NKX019 Discontinuation For R/R NHL And Pivot To Autoimmune Disorders
Seeking Alpha · 2026-09-03 -
Nkarta GAAP EPS of -$0.54 misses by $0.16
Seeking Alpha · 2026-08-10 -
Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
Yahoo Finance · 2026-08-10 -
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
Yahoo Finance · 2026-07-23 -
Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Yahoo Finance · 2026-06-26
No headlines in this category right now — try “All”.